Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Forum Bioscience" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Forum Bioscience for you to read. Along with our medical data and news we also list Forum Bioscience Clinical Trials, which are updated daily. BioPortfolio also has a large database of Forum Bioscience Companies for you to search.
One of the most influential minds in stem cell research, Dr. Rao will enhance Bio-Trac’s already strong hands-on research training workshop offerings as new Co-Director. GERMANTOWN, Md. (PRWEB) March 20, 2019 Bio-Trac®, a leading provider of graduate and postgraduate laboratory training workshops, announced today that regenerative medicine and stem cell research pioneer Dr. Mahendra S. Rao...
Michigan’s premier biosciences industry trade organization, MichBio, presents its annual Michigan Biosciences Day at the Capitol in Lansing, Michigan on Wednesday, April 10, 2019. The Biosciences Day at the Capitol is a unique opportunity for industry representatives to share their innovations and engage with decision-makers on behalf of their o...
NewsNew research examines hot spots of genetic variation within the human genome.Contributed Author:
Topical, transdermal sodium bicarbonate treatment significantly and safely reduced pain associated with an acute gout flare Dyve Bioscience, a biotech drug delivery company developing novel transdermal technologies for delivery of molecules through the skin, announced positive results from a human proof-of-concept pilot study of transdermal sodium bica...
Semi-micro, analytical, and precision balances will be on display at stand H77 MILTON KEYNES, United Kingdom (PRWEB) March 20, 2019 Adam Equipment, a leading provider of professional balances worldwide, will present lab balances, scales and accessories at stand H77 at Forum Labo Paris from 26-28 March at Paris expo Porte de Versailles in France. During the show, Adam will spotlight the Equinox se...
Los Angeles, California - March 20, 2019 (Newsfile Corp.) (Investorideas.com Newswire) NUGL Inc. (OTC PINK: NUGL) (the "Company"), a one-stop shop for all things cannabis through the intelligent connection of consumers and companies, is officially launching its social media platform
En ny studie som syftar till att minska sexuell exploatering av barn på internet kommer att rekrytera deltagare i forum på den krypterade delen av internet som kallas darknet.
Arix Bioscience PLC (LON:ARIX) investment director John Cassidy talks Proactive London through its decision to invest US$15mln (£11.3mln) in Imara - a firm which is developing treatments for sickle cell disease. Through the deal Arix receives a 10% stake in the company while also expanding the breadth of its portfolio.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. DeviceTalks is excited to announce that Tyler Shultz will be the closing keynote speaker at DeviceTalks Boston. Shultz will take attendees behind the story that eve...
Bozinovic comes from Biocom Institute to join the local bio organization as it turns 30 The Oregon Bioscience Association’s Board of Directors announced today the selection of its new Executive Director,
The fundraise was co-led by new investors OrbiMed Advisors and Arix Bioscience plc and included investment from RA Capital and Rock Springs Capital. Existing investors New Enterprise Associates, The post Imara closes a $63m Series B cross-over financing appeared first on Pharmaceutical Business review.
The fundraise was co-led by new investors OrbiMed Advisors and Arix Bioscience plc and included investment from RA Capital and Rock Springs Capital. Existing investors New Enterprise Associates, The post Imara closes $63m Series B cross-over financing appeared first on Pharmaceutical Business review.
(InSilico Medicine, Inc.) Dr. Nir Barzilai to present at the 6th Aging Research for Drug Discovery Forum in Basel.
WOBURN, Mass. , March 19, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN) announced today that the Company will report its fourth quarter and full year 2018 financial results and provide a corporate update on Monday, March 25, 2019. Management will host a business update conference call on Monday, March 25, 2019 at 4:30 p.m. eastern time to review financial results, corporate...
Imara Inc. raised $63mm through an oversubscribed Series B crossover round. New investors OrbiMed Advisors and Arix Bioscienc...
Virginia Bio, the statewide non-profit trade association for the life science industry, announced today that after seven years of service Jeff Gallagher CEO will step down from his position as CEO later this year, then will continue to serve the association on select special projects. A national search for a new CEO will begin immediately, conducted by the ...
Lundabaserade Alligator bioscience kandidat ATOR-1017 mot spridd cancer visar kraftfulla anti-tumöreffekter. Bolaget siktar på att starta studier i cancerpatienter senare i år.
It could be the first and only vaginally administered tamoxifen product approved by the FDA for the treatment of VVA in breast cancer patients
Life Sciences Industry Leader Andrew Setikas to Take the Helm of CLSA’s Business Development, Membership and Strategic Alliance Activities California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, today announced the appointment of Andrew Setikas as Senior Vice President of Business Develop...
New Highly-Sensitive Detection Technology using miRNA and snoRNA Expression Signatures Unveiled at EAU 2019 Proprietary, non-invasive liquid biopsy urine test definitively detects, accurately scores and continuously monitors prostate and bladder cancers miR Scienti
A recent study in Frontiers in Bioengineering and Biotechnology showed uBiome and its executives as top inventors in the microbiome industry. SAN FRANCISCO (PRWEB) March 18, 2019 uBiome, the leader in microbial genomics, has the largest patent portfolio in the microbiome industry and the third highest quality portfolio following Seres Health and Nestle, as published in Frontiers in Bioengineering...
LUND, Sweden, March 18, 2019 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announce that they will present preclinical data for the drug candidate ATOR-1017 at the 4th Annu...
-Proceeds to Advance IMR-687 for the Treatment of Sickle Cell Disease (SCD) and Thalassemia, and Expand Company Pipeline -New Investors: OrbiMed Advisors, Arix Bioscience, RA Capital, and Rock Springs Capital Imara Inc., a clinical-stage biopharmaceutical company focused on sickle cell disease (SCD) and other hemoglobinopathies, today announce...
US biotech Imara has raised $63 million for clinical development of its sickle cell disease drug, which is in mid-stage development. Imara attracted investors including Arix Bioscience, which has invested $15 million for a 10% stake, and will also...
The health and life science investor said the sum would give it a 10% stake in the company and expand the breadth of its portfolio